5 q-Syndrome and Monoclonal Gammopathy with α 1 Antitrypsin Deficiency

Van Den Berghe H. , Vermaelen K. , Mecucci C. , Barbieri D. , Tricot G. The 5q-anomaly. Cancer Genet Cytogenet 1985; 17: 189–256

Van Den Berghe H. The 5q-syndrome. Scand J Haematol 1986; 36(Suppl 45): 78–81

Dewald G.W. , Kyle R.A. , Hicks G.A. , Greipp P.R. The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia, or amyloidosis. Blood 1985; 66: 380–90

Sokal G. , Michaux J.L. , Van Den Berghe H. , A new haematologic syndrome with a distinct karyotype: the 5q-chromosome. Blood 1975; 46: 519–33

Raskind W.H. , Tirumali N. , Jacobson R. , Singer J. , Fialkow P.J. Evidence for a multistep pathogenesis of a myelodysplastic syndrome. Blood 1984; 63: 1318–23

Cox D.W. , Markovic V.D. , Teshima I.E. Genes for immunoglobulin heavy chains and for alpha 1-antitrypsin are localized to specific regions of chromosome 14q. Nature 1982; 297: 428–30

Breit S.N. , Wakefield D. , Robinson J.P. , Luckhurst E. , Clark P. , Penny R. The role of alphal-antitrypsin deficiency in the pathogenesis of immune disorders. Clin Immunol Immunopathol 1985; 35: 363–80

Szczeklik A. , Stachura J. , Pieton R. , Serwonska M. Marskosc watroby I dysimmunologlobulinemia U chorego Z niedoborem alpha 1 antytrypsyny o fenotype Pi M. Pol Arch Med Wewn 1977; 57: 533–7